September 15, 2025
How we use embeddings of clinical trial features to visualize and analyze the competitive biotech landscape.
Competitive Intel from What Biotech Does, Not What It Says
RxDataLab surfaces operational signals like hiring spikes, trial activity, regulatory filings, and patent shifts that help investors and strategy teams understand what biotech companies may do next.
Recent Analysis
View allAugust 3, 2025
A technical walkthrough of how I used LLMs strategically to improve name harmonization for clinical trial sponsors while minimizing non-determinism.
June 30, 2025
Learn how to parse SEC Form D filings into a private capital database for biotech and venture research.
Biotech intelligence built for analysts and agile teams
RxDataLab examines biotechnology companies by analyzing clinical trials, regulatory filings, patents, and hiring patterns—especially in neuroscience and AI-driven drug discovery. Our research combines scientific domain expertise with systematic alternative data analysis to assess what’s real, what’s likely, and what investors should watch next.
Ready to Talk?
Whether you're evaluating an investment opportunity, conducting due diligence, preparing for fundraising, or tracking competitive intelligence, We can provide the data and technical depth you need.
Get in Touch
Or email directly at
[email protected]
Stay Informed
Subscribe for research and analysis on emerging biotechnology and pharmaceutical developments.